The intestinal protozoan Entamoeba histolytica infects about 500,000,000 people worldwide; however, only about one-tenth develop clinically overt disease (8) . More tools are necessary to understand the epidemiology of the disease and to understand why nine-tenths of those infected are asymptomatic. One of the critical questions in amebiasis has been whether the large number of asymptomatic carriers reflects differences in the pathogenic potential of the infecting strain or variation in the host response to infection.
Evidence for inherent differences in virulence among E. histolytica isolates has been provided by Sargeaunt and colleagues. They have demonstrated the existence of differences in isoenzyme patterns (zymodemes) between xenically cultured E. histolytica isolates from patients with invasive disease versus those obtained from asymptomatic carriers (17) . This system of isoenzyme analysis, based on the study of isoenzyme patterns from thousands of clinical isolates obtained around the world, enables one to predict whether a given isolate can cause disease and can provide information on the geographic origin of the strain (16) . In general, only strains possessing a pathogenic zymodeme have been cultivated in axenic culture. While attempting to culture a nonpathogenic strain of E. histolytica axenically, Mirelman and colleagues observed that its zymodeme pattern changed from nonpathogenic to pathogenic (13) .
Recently, E. histolytica-specific DNA probes which distinguish pathogenic from nonpathogenic clinical isolates (2, 7, 20) and may serve as valuable diagnostic reagents (15) have been developed. A strain-specific cDNA probe could prove useful for rapid typing of E. histolytica strains and might provide further insight into the epidemiology and molecular pathogenesis of amebic disease. We report here the isolation of a strain-specific E. histolytica cDNA clone that distinguishes between axenically cultured strains pos-* Corresponding author.
sessing the same pathogenic zymodeme. Furthermore, this clone hybridizes specifically to DNAs extracted from xenically cultured E. histolytica strains possessing pathogenic zymodemes while not hybridizing to DNAs extracted from organisms possessing nonpathogenic zymodemes.
MATERIALS AND METHODS
Entamoeba strains and culture conditions. Axenic E. histolytica HM1:IMSS, HK-9, 200:NIH, and Rahman (all belonging to pathogenic zymodeme II); the E. histolytica-like Laredo strain; E. invadens; and E. moshkovskii were obtained from the American Type Culture Collection (Gaithersburg, Md.) and cultivated in TYI-S-33 medium (4) . The E. histolytica strains were grown at 35°C, and the other amebic species were grown at 24°C. Clinical isolates of E. histolytica (Table 1) were all obtained from stool or liver abscess fluid. They were isolated and maintained in Robinson's medium (14) (except strain FAT957, which was originally isolated in Locke egg medium [22] before transfer to Robinson's medium). Zymodeme analysis was performed as described by Sargeaunt et al. (17) .
Construction and screening of an HM1:IMSS cDNA library. A pUC13 cDNA library derived from HM1:IMSS poly(A)+ RNA was constructed in Escherichia coli DH5cx [genotype: F-endAl hsdR17 (rK-mK) supE44 thi-l X-recAl gyrA'96 relAl A(argF-lacZYA)U169 480dlacZAM15] as described previously (18) . Duplicate replica filters representing approximately 10,000 of the recombinants were probed with 32P-labeled single-stranded cDNAs from HM1:IMSS and the E. histolytica-like Laredo strain, respectively. DNA probes. An actin cDNA probe was isolated by using oligonucleotides based on the sequence of HM1:IMSS actin cDNA previously described (5) . Clone Cl, which encodes a unique E. histolytica membrane antigen, has been previously described (18) . A DNA probe encoding E. histolytica rRNA (15) (10) .
RNA transfer blot analysis. RNA was isolated from trophozoites by the guanidinium thiocyanate method as previously described (18) . Northern (RNA) blots were prepared by electrophoresing 20 ,ug of total cellular amebic RNA from each axenic strain through a 1.5% agarose gel containing formaldehyde (21) (Fig. 4, lanes 2 and 4) . Note that the transcripts that hybridized with oligol (which hybridized to the 5' end of the sense strand of C2) were larger than the predominant transcript that hybridized to the C2 clone itself. Oligol hybridized predominantly to 3.5-and 5.2-kb transcripts, in addition to a 0.7-kb transcript, suggesting that C2 represents part of a much larger transcript that is processed.
To isolate cDNA clones that overlap C2 at the 5' and 3' ends, the HM1:IMSS cDNA library was rescreened by using oligo3 (GTAGTTTGCTAGATTTTATC), which hybridized with the 3' end of the sense strand, and oligol. A second clone, C2a, which was obtained by screening the cDNA library with oligo3, corresponds exactly to nucleotides 99 to 690 of C2 but is polyadenylated (Fig. 3B) from patients with invasive disease, including SAW1453, SD53, FAT957, SAW990, SD92, FAT1014, and FAT967 (Fig. 6 ). These isolates all expressed pathogenic zymodemes. Positive signals were observed after overnight expopure, although the signals varied in intensity. The samples yielding no hybridization signal after a minimum of 3 days of exposure included strains SD11, SD126, SD130, SD116, SD107, and FAT1010, all possessing nonpathogenic zymodemes and from patients without evidence of invasive disease. Three of the seven positive isolates were from patients with colitis, three were from patients with liver abscesses, and the seventh was from an asymptomatic child with positive serology. Of the six negative strains, five were from homosexual men, three of whom had AIDS. The sixth was from an asymptomatic South African child.
To control for the presence of DNA in the six isolates that did not hybridize to C2, a DNA probe encoding E. histolytica rRNA (15) was used. A positive signal was seen in each of the six blots, confirming the presence of DNA in each sample (data not shown).
DISCUSSION
A number of studies have suggested that biochemical and immunological differences exist between E. histolytica isolated from patients with invasive amebiasis and E. histolytica isolated from asymptomatic carriers (17, 19) . Recently molecular probes have confirmed differences at the genetic level between pathogenic and nonpathogenic isolates (7, 20) . Less (15) . The high sensitivity of the C2 cDNA clone may be due in part to the nine 26-nucleotide repeats present in its 3' end.
Dot blot analysis of DNAs extracted from xenically cultured E. histolytica trophozoites revealed that C2 distinguished strains with pathogenic zymodemes from those with nonpathogenic zymodemes. Hybridization signals could be detected in all seven of the xenic strains bearing pathogenic zymodemes that hybridized with the C2 clone. Thus, in this small sample we could not distinguish strain differences in the expression or presence of the gene corresponding to C2 among xenically cultured clinical isolates which possessed pathogenic zymodemes. A larger sample of clinical isolates, from various geographical regions, will be necessary to approach the critical question of whether the genetic differences we detected among axenic strains also exist among xenically cultured clinical isolates. The answer to this question will bear on the utility of clone C2 as a strain-specific marker and on the broader point of the effects of axenization on the E. histolytica genome.
The C2 clone differs from some of the previously reported E. histolytica-specific DNA probes (2, 7, 15) 
